Moves to recall Andrographis products gathers pace


Swisse, API, Nova Pharmaceuticals and an exclusive Chemist Warehouse brand among the latest to recall products containing Andrographis   The Therapeutic Goods Administration (TGA) has announced that six medicines sponsors have confirmed the recall of nine more Andrographis containing medications.  The move comes a month after the regulator revealed that new medicines containing Andrographis paniculata (Andrographis)

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘AI will take on the work that eats our days’
This is the most recent story.